262 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
151 | 12668898 | Prevention and treatment of reactions to NSAIDs. | 2003 Apr | 1 |
152 | 12705064 | Selective COX-2 inhibitors: a health economic perspective. | 2003 | 1 |
153 | 12723742 | Relative efficacy of selective COX-2 inhibitors compared with over-the-counter ibuprofen. | 2003 Apr | 1 |
154 | 12723745 | Risk factors associated with the development of gastroduodenal ulcers due to the use of NSAIDs. | 2003 Apr | 1 |
155 | 12740337 | Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study. | 2003 Jun | 1 |
156 | 12749519 | A model analysis of costs of blood pressure destabilization and edema associated with rofecoxib and celecoxib among older patients with osteoarthritis and hypertension in a Medicare Choice population. | 2003 Feb | 1 |
157 | 12782016 | The role of COX-2 in angiogenesis and rheumatoid arthritis. | 2003 Jun | 1 |
158 | 12783912 | Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. | 2003 Jun 4 | 1 |
159 | 12816152 | Intolerance reactions due to the selective cyclooxygenase type II inhibitors rofecoxib and celecoxib. Results of oral provocation tests in patients with NSAID hypersensitivity. | 2003 | 1 |
160 | 12818939 | An evaluation of the safety and efficacy of administering rofecoxib for postoperative pain management. | 2003 Jul | 1 |
161 | 12845388 | Effects of renal insufficiency and hemodialysis on the pharmacokinetics of rofecoxib. | 2003 Jul-Aug | 2 |
162 | 12859668 | Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia. | 2003 Aug | 3 |
163 | 12868201 | [Coxibs: highly selective cyclooxygenase-2 inhibitors. Part II. Side effects]. | 2003 Apr | 1 |
164 | 12890715 | Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin. | 2003 Aug | 1 |
165 | 12902855 | COX-2 inhibitors and cancer therapeutics: potential roles for inhibitors of COX-2 in combination with cytotoxic therapy: reports from a symposium held in conjunction with the Radiation Therapy Oncology Group June 2001 Meeting. | 2003 Aug | 2 |
166 | 12906745 | Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects. | 2003 Jul | 1 |
167 | 12910695 | [The effects of selective cyclooxygenase-2 inhibitors on the growth of gastric adenocarcinoma]. | 2003 Jul | 1 |
168 | 12941996 | Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials. | 2003 May 1 | 1 |
169 | 12975714 | A retrospective review of the effect of COX-2 inhibitors on blood pressure change. | 2003 Sep-Oct | 1 |
170 | 14504873 | A comparative study of the effect of rofecoxib (a COX 2 inhibitor) and naproxen sodium on analgesic requirements after abdominal hysterectomy. | 2003 Oct | 1 |
171 | 14524083 | [Selective COX 2 inhibitor rofecoxib. To "defy" the pain]. | 2003 Aug 7 | 1 |
172 | 14530224 | Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial. | 2003 Oct 7 | 1 |
173 | 14552704 | Clinical pharmacology of selective COX-2 inhibitors. | 2003 May-Aug | 1 |
174 | 14585914 | Persistency of use of COX-2-specific inhibitors and non-specific non-steroidal anti-inflammatory drugs (NSAIDs) in Quebec. | 2003 Nov | 1 |
175 | 14592550 | Obligatory role of lipid mediators in platelet-neutrophil adhesion. | 2003 Jun 15 | 1 |
176 | 14627347 | Rofecoxib reduces polyp recurrence in familial polyposis. | 2003 Oct | 1 |
177 | 14655004 | [Clinical pharmacology of the selective COX-2 inhibitors]. | 2003 Dec | 1 |
178 | 15071803 | High performance liquid chromatographic determination of cox-2 inhibitor rofecoxib in human plasma. | 2003 Aug | 1 |
179 | 15199473 | Aspirin and other cyclooxygenase inhibitors: new therapeutic insights. | 2003 May | 2 |
180 | 11866383 | A rapid and sensitive high-performance liquid chromatography assay for rofecoxib in human serum. | 2002 Jan | 1 |
181 | 11898894 | Gastrointestinal bleeds associated with rofecoxib. | 2002 Mar | 1 |
182 | 11909557 | Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema. | 2002 Mar 21 | 1 |
183 | 11940070 | Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs. | 2002 Mar | 1 |
184 | 11945113 | Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution. | 2002 | 1 |
185 | 11992745 | Renal effects of cyclooxygyenase-2-selective inhibitors. | 2002 Apr | 1 |
186 | 12017215 | A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents. | 2002 | 1 |
187 | 12065343 | Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma. | 2002 Jun | 1 |
188 | 12086291 | Gastrointestinal safety and tolerability of nonselective nonsteroidal anti-inflammatory agents and cyclooxygenase-2-selective inhibitors. | 2002 | 1 |
189 | 12100094 | Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study. | 2002 May | 1 |
190 | 12113843 | Fatal hyperkalemia related to combined therapy with a COX-2 inhibitor, ACE inhibitor and potassium rich diet. | 2002 May | 1 |
191 | 12126328 | What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex). | 2002 Jun 25 | 2 |
192 | 12141411 | Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman's syndrome. | 2002 Jul | 1 |
193 | 12198983 | Selecting new drugs for pain control: evidence-based decisions or clinical impressions? | 2002 Aug | 1 |
194 | 12204486 | The impact of pain management on quality of life. | 2002 Jul | 1 |
195 | 12217369 | Isomeric acetoxy analogues of rofecoxib: a novel class of highly potent and selective cyclooxygenase-2 inhibitors. | 2002 Oct 7 | 2 |
196 | 12220285 | Rofecoxib-induced instant aquagenic wrinkling of the palms. | 2002 Jul-Aug | 1 |
197 | 12389882 | Cyclooxygenase-2 inhibitor-associated acute renal failure: case report with rofecoxib and review of the literature. | 2002 Oct | 1 |
198 | 12395741 | [Anti-inflammatory non-steroidal selective cyclooxygenase 2 inhibitors and gastroduodenal lesions]. | 2002 Sep 28 | 1 |
199 | 12406411 | [Economic evaluation of a new selective COX-2 NSAID, rofecoxib, in a real practice context]. | 2002 Oct 31 | 1 |
200 | 12410658 | Factor-sparing use of the COX-2 inhibitor rofecoxib in haemophilic arthropathy. | 2002 Nov | 1 |